KEGG   DRUG: ErlizumabHelp
Entry
D04045                      Drug                                   

Name
Erlizumab (USAN/INN)
Efficacy
Immunosuppressant, Anti-CD18 antibody
Comment
Monoclonal antibody
Adjunctive treatment to reperfusion therapy in acute myocardial infarction or other types of reperfusion therapy
Target
ITGB2/ITGAL [HSA:3689 3683] [KO:K06464 K05718]
  Pathway
hsa04514  Cell adhesion molecules (CAMs)
hsa04650  Natural killer cell mediated cytotoxicity
hsa04670  Leukocyte transendothelial migration
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: other families
   Integrins
    ITGB2/ITGAL
     D04045  Erlizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 211323-03-4
PubChem: 47206008
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system